Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor.

Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor.

The DDR1 receptor tyrosine kinase is activated by matrix collagens and has been implicated in numerous cellular functions such as proliferation, differentiation, adhesion, migration, and invasion. Here we report the discovery of a potent and selective DDR1 inhibitor, DDR1-IN-1, and present the 2.2 Å...

Podrobná bibliografie
Hlavní autoři:	Kim, H, Tan, L, Weisberg, E, Liu, F, Canning, P, Choi, H, Ezell, SA, Wu, H, Zhao, Z, Wang, J, Mandinova, A, Griffin, J, Bullock, A, Liu, Q, Lee, S, Gray, N
Médium:	Journal article
Jazyk:	English
Vydáno:	2013

Podobné jednotky

Correction to Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor.
Autor: Kim, H, a další
Vydáno: (2014)

Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors
Autor: Canning, P, a další
Vydáno: (2014)

Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors.
Autor: Canning, P, a další
Vydáno: (2014)

Tyrosine Kinase Inhibitors Display Potent Activity against Cryptosporidium parvum
Autor: Maria G. Nava, a další
Vydáno: (2023-02-01)

New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.
Autor: López-Ramos, M, a další
Vydáno: (2010)

New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.
Autor: López-Ramos, M, a další
Vydáno: (2010)

Inhibitors of Discoidin Domain Receptor (DDR) Kinases for Cancer and Inflammation
Autor: William A. Denny, a další
Vydáno: (2021-11-01)

Editorial: Discovery of EGFR tyrosine kinase inhibitors for cancer treatment
Autor: Panupong Mahalapbutr, a další
Vydáno: (2024-02-01)

Discovery of Novel Naphthoquinone–Chalcone Hybrids as Potent FGFR1 Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Molecular Modeling
Autor: Ronnakorn Leechaisit, a další
Vydáno: (2023-08-01)

Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.
Autor: Patrice Dubreuil, a další
Vydáno: (2009-09-01)

Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors
Autor: Xu H, a další
Vydáno: (2019-07-01)

Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors
Autor: Sudarshan R Iyer, a další
Vydáno: (2023-10-01)

Recent Advances in Discovery of New Tyrosine Kinase Inhibitors Using Computational Methods
Autor: Vesna Rastija
Vydáno: (2019-08-01)

Bioactive Phytoconstituents as Potent Inhibitors of Tyrosine-Protein Kinase Yes (YES1): Implications in Anticancer Therapeutics
Autor: Chunmin Yang, a další
Vydáno: (2022-05-01)

Small-molecule inhibitors of the c-Fes protein-tyrosine kinase.
Autor: Hellwig, S, a další
Vydáno: (2012)

New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights (September, pg 3175, 2010)
Autor: Lopez-Ramos, M, a další
Vydáno: (2011)

Kindlin-3 inactivation mediates melanoma agressiveness through crosstalk with the collagen-activated tyrosine kinase receptor DDR1
Autor: C. Reger de Moura, a další
Vydáno: (2024-01-01)

Selective Akt inhibitors synergize with tyrosine kinase inhibitors and effectively override stroma-associated cytoprotection of mutant FLT3-positive AML cells.
Autor: Ellen Weisberg, a další
Vydáno: (2013-01-01)

First‐in‐human study of deucravacitinib: A selective, potent, allosteric small‐molecule inhibitor of tyrosine kinase 2
Autor: Ian M. Catlett, a další
Vydáno: (2023-01-01)

TYROSINE KINASE INHIBITORS AND INTERFERON
Autor: Maria Dimou, a další
Vydáno: (2014-01-01)

TYROSINE KINASE INHIBITORS AND PREGNANCY
Autor: Elisabetta Abruzzese, a další
Vydáno: (2014-04-01)

Second-generation inhibitors of Bruton tyrosine kinase
Autor: Jingjing Wu, a další
Vydáno: (2016-09-01)

Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and IGF-1R
Autor: Cornelius Hempel, a další
Vydáno: (2017-01-01)

Discovery of Novel N-Substituted Prolinamido Indazoles as Potent Rho Kinase Inhibitors and Vasorelaxation Agents
Autor: Yangyang Yao, a další
Vydáno: (2017-10-01)

Tyrosine Kinase Inhibitors in Pulmonary Vascular Disease
Autor: John J. Ryan, MD
Vydáno: (2016-12-01)

Exploration of type II binding mode: A privileged approach for kinase inhibitor focused drug discovery?
Autor: Zhao, Z, a další
Vydáno: (2014)

The two facets of receptor tyrosine kinase in cardiovascular calcification—can tyrosine kinase inhibitors benefit cardiovascular system?
Autor: Ainun Nizar Masbuchin, a další
Vydáno: (2022-09-01)

Tyrosine kinase inhibitor Tofacitinib. Safety issues
Autor: G. V. Lukina, a další
Vydáno: (2015-12-01)

Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma
Autor: Huang JT, a další
Vydáno: (2022-11-01)

Dual inhibition of Fes and Flt3 tyrosine kinases potently inhibits Flt3-ITD+ AML cell growth.
Autor: Mark C Weir, a další
Vydáno: (2017-01-01)

miR-494 in Extracellular Vesicles as a Potent Biomarker of Chronic Myeloid Leukemia Treatment with Tyrosine Kinase Inhibitors
Autor: Tatsuki Shibuta, a další
Vydáno: (2022-06-01)

Vorolanib, a novel tyrosine receptor kinase receptor inhibitor with potent preclinical anti-angiogenic and anti-tumor activity
Autor: Chris Liang, a další
Vydáno: (2022-03-01)

Mechanism and treatment of diarrhea associated with tyrosine kinase inhibitors
Autor: Jiangnan Liu, a další
Vydáno: (2024-03-01)

Acquired Hypothyroidism in Patients with Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors
Autor: Wu J, a další
Vydáno: (2020-09-01)

Integrating machine learning and structure-based approaches for repurposing potent tyrosine protein kinase Src inhibitors to treat inflammatory disorders
Autor: Muhammad Waleed Iqbal, a další
Vydáno: (2025-01-01)

Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment
Autor: Pitsiou G, a další
Vydáno: (2014-10-01)

509 Potent and selective inhibition Of AXL receptor tyrosine kinase for the treatment of cancer
Autor: Matthew Walters, a další
Vydáno: (2020-11-01)

Activation of transmembrane receptor tyrosine kinase DDR1-STAT3 cascade by extracellular matrix remodeling promotes liver metastatic colonization in uveal melanoma
Autor: Wei Dai, a další
Vydáno: (2021-05-01)

Tetrahydroisoquinoline-7-carboxamide derivatives as new selective discoidin domain receptor 1 (DDR1) inhibitors
Autor: Bullock, A, a další
Vydáno: (2017)

Receptor Tyrosine Kinases and Inhibitors in Lung Cancer
Autor: Evan Pisick, a další
Vydáno: (2004-01-01)